Alacizumab (Anti-VEGFR2 / KDR / CD309)
Alacizumab (Anti-VEGFR2 / KDR / CD309) is a humanized monoclonal antibody targeting VEGFR2 / KDR / CD309 . It has anti-tumour effect in tumour growth. MW :144.08 KD.
| Trivial name | CDP791 |
| Catalog Number | A3109 |
| CAS# | 934216-54-3 |
| Size | 1mg |